In individuals with obesity and dyslipidemia, the increase in Ox-LDL levels can be attributed to a reduction in the antioxidant defense mechanisms, primarily due to the decreased activity of enzymes like superoxide dismutase (SOD) and paraoxonase-1 (PON-1) associated with HDL. This evidence concerns the gene PON1 and obesity due to melanocortin 4 receptor deficiency.